Lecanemab trial in AD brings hope but requires greater clarity
Crossref DOI link: https://doi.org/10.1038/s41582-022-00768-w
Published Online: 2023-01-06
Published Print: 2023-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Thambisetty, Madhav
Howard, Robert
Text and Data Mining valid from 2023-01-06
Version of Record valid from 2023-01-06
Article History
First Online: 6 January 2023
Competing interests
: The authors declare no competing interests.